SandraMetaSwainMD

Oncology • Bethesda, MD

Professor, Medicine, Georgetown University School of Medicine

Join to view full profile

Dr. Swain is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Swain's full profile

Already have an account?

Office
8901 Wisconsin Ave Bldg 8 Room 5101
Bethesda, MD 20889
Phone+1 301-435-5416

Fax+1 301-496-0047

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1983 - 1986
Vanderbilt University Medical CenterResidency, Internal Medicine, 1980 - 1983
University of Florida College of MedicineClass of 1980

Certifications & Licensure

MD State Medical License 1983 - 2025
DC State Medical License 1988 - 2024
TX State Medical License 1996 - 2024
IL State Medical License 1989 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
Super Doctor SuperDoctors.com

Clinical Trials

Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer Start of enrollment: 2002 May 01
Completed
Phase 2
Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer Start of enrollment: 2004 Oct 01
Completed
Phase 3
Solid Tumors Using Ixabepilone and Dasatinib Start of enrollment: 2008 Jul 01
Completed
Phase 1
Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer Start of enrollment: 2009 Feb 01
Terminated
Phase 2
Cardiac Safety Study in Patients With HER2 + Breast Cancer Start of enrollment: 2013 Oct 01
Completed
Phase 2
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread Start of enrollment: 2014 Jun 10
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

27 citations
Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combi...
Sandra M. Swain, Gong Tang, Peter C. Lucas, André Robidoux, David Goerlitz
Breast Cancer Research and Treatment. 2019-08-19
143 citations
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
Rosie Bradley, Jeremy P Braybrooke, Richard Gray, Robert Kerrin Hills, Z Liu
The Lancet. Oncology. 2021-08-01
162 citations
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results fro...
Sandra M. Swain, José Baselga, David Miles, Y-H. Im, C. Quah
Annals of Oncology. 2014-06-01

Journal Articles

Left Ventricular Ejection Fraction Monitoring Adherence Rates
Chau T Dang, Sandra M Swain, Anne Blaes, ScienceDirect
Take Care of Your Neighborhood
Elmer E Huerta, Sandra M Swain, Breast Cancer Research and Treatment

Lectures

NSABP B-41, a randomized neoadjuvant trial: Genes and signatures associated with pathologic complete response (pCR).
2019 ASCO Annual Meeting - 6/1/2019
End-of-study analysis from the phase III, randomized, double-blind, placebo (Pla)-controlled CLEOPATRA study of first-line (1L) pertuzumab (P), trastuzumab (H), and do...
2019 ASCO Annual Meeting - 6/1/2019
Intrinsic subtypes of HER2-positive breast cancer and their associations with pathologic complete response (pCR) and outcomes: Findings from NSABP B-41, a randomized n...
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
HSCO Educational Symposium - ASCO Update
Hawaii Society of Clinical Oncology (HSCO), Honolulu, Hawaii - 7/9/2013
Join now to see all

Press Mentions

Charles B. Hammond, M.D.,September 30th, 2024
NanoString Announces the Creation of the GeoMx Breast Cancer ConsortiumDecember 11th, 2019
During Breast Cancer Awareness Month, Don’t Forget to Check the Heart!October 18th, 2019
Join now to see all

Grant Support

Inflammatory Breast CancerNational Cancer Institute2007
Developmental TherapeuticsNational Cancer Institute2007
Breast Cancer PreventionNational Cancer Institute2007
Adjuvant Therapy Of Breast CancerNational Cancer Institute2007
Breast Cancer PreventionDivision Of Basic Sciences - Nci2006
Adjuvant Therapy Of Breast CancerDivision Of Basic Sciences - Nci2005–2006
Developmental TherapeuticsDivision Of Basic Sciences - Nci2001–2006
Inflammatory Breast CancerDivision Of Clinical Sciences - Nci2000–2006